Physician profile
Amber D Hyde
NPI 1902083082
$4,994.87
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,995.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi US Services INC. | $3,942.86 | 2019 | |
| Novo Nordisk INC | $283.97 | 2019 | |
| Pfizer INC. | $116.59 | 2019 | |
| Lilly USA, LLC | $83.40 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $82.61 | 2019 | |
| Amgen INC. | $64.40 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $64.32 | 2019 | |
| Sanofi Pasteur INC. | $41.39 | 2019 | |
| Antares Pharma, INC. | $35.30 | 2019 | |
| Amarin Pharma, INC. | $34.53 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $30.72 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.94 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.14 | 2019 | |
| Titan Pharmaceuticals, INC. | $24.55 | 2019 | |
| Abbott Laboratories | $21.03 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $19.09 | 2019 | |
| Abbvie INC. | $18.88 | 2019 | |
| Cardiovascular Systems INC. | $18.11 | 2019 | |
| Glaxosmithkline, LLC. | $16.66 | 2019 | |
| Mdd US Operations, LLC | $13.94 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $13.83 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.61 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Hyde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.